Rimed is one of the leading medical radiology groups in Switzerland.
Investment thesis
Providing a unique healthcare platform for patients, referring physicians, and hospitals with a patient-oriented service approach covering a wide range of high-quality diagnostics services.
Achievements
- In 2022, Rimed joined forces with Unilabs to create an integrated medical diagnostics group to support patients and doctors with a comprehensive diagnostic offer from one single source. In the course of this transaction, Luxempart reduced its stake in Rimed from 27.4% to 5.5%
- Luxempart had originally partnered up with the founder of Rimed in 2016 to support the buy & build strategy across Switzerland. Over the course of this partnership, from 2016 until 2022, revenues grew by over 60%